"Enoxaparin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed)
| Descriptor ID |
D017984
|
| MeSH Number(s) |
D09.698.373.400.300.200
|
| Concept/Terms |
PK-10,169- PK-10,169
- PK 10,169
- PK10,169
- PK-10169
- PK 10169
- PK10169
|
Below are MeSH descriptors whose meaning is more general than "Enoxaparin".
Below are MeSH descriptors whose meaning is more specific than "Enoxaparin".
This graph shows the total number of publications written about "Enoxaparin" by people in this website by year, and whether "Enoxaparin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 2 | 4 |
| 2017 | 7 | 5 | 12 |
| 2018 | 10 | 3 | 13 |
| 2019 | 5 | 2 | 7 |
| 2020 | 9 | 13 | 22 |
| 2021 | 13 | 5 | 18 |
To return to the timeline, click here.
Below are the most recent publications written about "Enoxaparin" by people in Profiles.
-
COVID-19 and Hepatic Artery Thrombosis: A Case Report. Am J Case Rep. 2021 Aug 01; 22:e932531.
-
Acetylsalicylic Acid Compared with Enoxaparin for the Prevention of Thrombosis and Mechanical Ventilation in COVID-19 Patients: A Retrospective Cohort Study. Clin Drug Investig. 2021 Aug; 41(8):723-732.
-
Pharmacokinetics of enoxaparin in COVID-19 critically ill patients. Thromb Res. 2021 09; 205:120-127.
-
Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: A multi-center, open-label, randomized controlled trial. J Thromb Haemost. 2021 09; 19(9):2225-2234.
-
High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia. Chest. 2021 07; 160(1):e94-e95.
-
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. Lancet. 2021 06 12; 397(10291):2253-2263.
-
DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination. Viruses. 2021 06 01; 13(6).
-
Incidence of deep vein thrombosis through an ultrasound surveillance protocol in patients with COVID-19 pneumonia in non-ICU setting: A multicenter prospective study. PLoS One. 2021; 16(5):e0251966.
-
Massive Pulmonary Embolism in an Adolescent With Multisystem Inflammatory Syndrome Due to COVID-19. Clin Pediatr (Phila). 2021 07; 60(8):341-345.
-
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. BMJ. 2021 05 11; 373:n1038.